• Home

  • Our Company

    Our Company

    • About Us

    • A Legacy of Innovation

    • Our Strategic Priorities

    • Our Honors

  • Products & Solutions

    Products & Solutions

    • Dog

      • Biologics

    • Cat

      • Dermatology

      • Urology

      • Sub-healthy

      • Respiratory system

      • Ophthalmology

      • Oral Health

  • News

    News

    • Company News

  • Contact

  • Language

    Language

    • 中文

    • English

  • Help & Inquiry

中文版

Help & Inquiry

Taizhou Bolaideli Biotechnology Co., Ltd.
  • Home page

Ten Years of Steadfast Dedication, Qingdao Medical University Reaches New Heights


Ten Years of Steadfast Dedication, Qingdao Medical University Reaches New Heights

2026-02-27

Summary: The 17th East–West Small Animal Clinical Veterinarians Conference Grandly Presents the Bolaideli Outstanding Young Veterinarian Award


 

Previous Page

None

Announcement of the Winners of the Outstanding Young Veterinarian Award at the 16th East–West Small Animal Clinical Veterinary Conference by Bolaideli (Part 1)

Next page

Previous Page

None

Next page

Announcement of the Winners of the Outstanding Young Veterinarian Award at the 16th East–West Small Animal Clinical Veterinary Conference by Bolaideli (Part 1)

Other News

Bolaideli: Reimagining China’s pet biopharmaceutical landscape through original, innovative research.

2026-07-13

Bolaideli: Reimagining China’s pet biopharmaceutical landscape through original, innovative research.

Good News | Taizhou Bolaideli Has Successfully Been Awarded the 2026 Jiangsu Province Quality and Credit Grade A Enterprise Status

2026-07-09

Good News | Taizhou Bolaideli Has Successfully Been Awarded the 2026 Jiangsu Province Quality and Credit Grade A Enterprise Status

“China’s Strength” Emerges in the Pet Biopharmaceutical Sector — Insights into the Breakthroughs of Chinese Pet Pharmaceutical Companies from the Approval of Two Class II New Veterinary Drugs

2025-11-10

“China’s Strength” Emerges in the Pet Biopharmaceutical Sector — Insights into the Breakthroughs of Chinese Pet Pharmaceutical Companies from the Approval of Two Class II New Veterinary Drugs

Bolaideli

Contact Us

WeChat
Xiaohongshu
TikTok
Taobao
JD.com
  • Home

  • Our Company

    • About Us

    • A Legacy of Innovation

    • Our Strategic Priorities

    • Our Honors

  • Products & Solutions

    • Dog

      • Biologics

    • Cat

      • Dermatology

      • Urology

      • Sub-healthy

      • Respiratory system

      • Ophthalmology

      • Oral Health

  • News

    • Company News

  • Contact

  • Language

    • 中文

    • English

  • Help & Inquiry

Search
%{tishi_zhanwei}%

Copyright © 2026 Taizhou BioAlly Biotechnology Co., Ltd.

Powered by: www.300.cn |Tags